Molecular and Cell Biology of Lung Carcinoma

作者: W. A. Franklin , F. R. Hirsch

DOI: 10.1007/978-3-642-18698-1_1

关键词: BioinformaticsEpidermal growth factor receptorLung cancerNormal tissueCellEpigeneticsLungInternal medicineBiologyAnatomic LocationCarcinomaOncology

摘要: Lung carcinoma is currently perceived to be the result of complex mutational and epigenetic changes in epithelial cells lung that impart those a high capacity for proliferation, resistance programmed cell (apoptosis), ability invade destroy normal tissue metastasize. cancer achieve these properties through series genomic are highly heterogeneous with respect timing their occurrence, complexity, anatomic location affected specific molecular pathways affected. Defining changes, devising methods measuring them large patient populations taking advantage therapeutic protocols will continue most daunting challenges research foreseeable future. In recent years, there has been increase available cellular information this field. This review attempts relate well-established data clinical problem premalignancy. Numerous references referring more detailed reviews provided convenience interested further reading.

参考文章(181)
Joseph R. Testa, Jill M. Siegfried, Zemin Liu, Jay D. Hunt, Madelyn M. Feder, Samuel Litwin, Jian-Yuan Zhou, Takahiro Taguchi, Steven M. Keller, Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes, Chromosomes and Cancer. ,vol. 11, pp. 178- 194 ,(1994) , 10.1002/GCC.2870110307
Shin-ichi Toyooka, Mamoru Ouchida, Yoshimi Jitsumori, Kazunori Tsukuda, Akiko Sakai, Akio Nakamura, Nobuyoshi Shimizu, Kenji Shimizu, HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3. Biochemical and Biophysical Research Communications. ,vol. 278, pp. 671- 678 ,(2000) , 10.1006/BBRC.2000.3870
S. L. Naylor, B. E. Johnson, J. D. Minna, A. Y. Sakaguchi, Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer Nature. ,vol. 329, pp. 451- 454 ,(1987) , 10.1038/329451A0
J. Whang-Peng, P.A. Bunn, C.S. Kao-Shan, E.C. Lee, D.N. Carney, A. Gazdar, J.D. Minna, A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer (SCLC) Cancer Genetics and Cytogenetics. ,vol. 6, pp. 119- 134 ,(1982) , 10.1016/0165-4608(82)90077-2
G Cox, Angiogenesis and non-small cell lung cancer. web science. ,vol. 27, pp. 81- 100 ,(2000) , 10.1016/S0169-5002(99)00096-3
Liang Wang, John Darling, Jin-San Zhang, Wanguo Liu, Junqi Qian, David Bostwick, Lynn Hartmann, Robert Jenkins, Walter Bardenhauer, Jochen Schutte, Bertram Opalka, David I. Smith, Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes, Chromosomes and Cancer. ,vol. 27, pp. 1- 10 ,(2000) , 10.1002/(SICI)1098-2264(200001)27:1<1::AID-GCC1>3.0.CO;2-6
MELVYN S. TOCKMAN, Airways Obstruction and the Risk for Lung Cancer Annals of Internal Medicine. ,vol. 106, pp. 512- 518 ,(1987) , 10.7326/0003-4819-106-4-512
Fadlo R. Khuri, Bonnie L. Kemp, Jean Pierre Issa, Li Mao, Jonathan M. Kurie, Janet I. Lee, Diane D. Liu, Luo Wang, Jean Charles Soria, Ho Young Lee, Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clinical Cancer Research. ,vol. 8, pp. 1178- 1184 ,(2002)